Finance and funding: latest news

Finance and funding features

Finance and funding news from aidsmap

More news

Finance and funding news selected from other sources

  • Gilead Ignored HIV Groups Before Failed Bid To Have PrEP Subsidised In Australia

    A drug manufacturer failed to take the advice of top HIV/AIDS organisations when it made a submission for a highly effective HIV prevention drug to be subsidised by the government, those organisations say.

    25 August 2016 | BuzzFeed
  • HIV prevention drug Truvada won't be subsidised in Australia

    Truvada, an expensive breakthrough drug that prevents people from getting HIV won't be funded by taxpayers in Australia this year, the nation's drug funding panel has ruled. A Department of Health spokeswoman said the PBAC understood "this is an important new prevention medication for HIV", but decided the price set by the drug's sponsor, Gilead Sciences, was too high and a proposal to limit subsidy to a small subset of the "at risk" group was not feasible. "In its deliberations the PBAC indicated a substantial price reduction would be needed to make Truvada available for PrEP for the whole 'at risk' population, but noted that Truvada for PrEP could represent value for money in the broader population at a substantially lower price," the spokeswoman said.

    19 August 2016 | Sydney Morning Herald
  • Hillary Clinton calls out drug maker Gilead over price of hepatitis C pills

    Democratic presidential nominee Hillary Clinton said Wednesday her administration will go after drug companies that charge exorbitant prices, singling out the company Gilead, whose hepatitis C drugs cost between $900 and $1,000 per pill in the United States.

    19 August 2016 | UPI.com
  • Today In History, 1990: President George H.W. Bush Signs the Ryan White CARE Act

    Since the earliest days of the AIDS epidemic, the nation’s response to the deadly disease was chronically slow and woefully underfunded. Much of the resistance to increased funding stemmed from open hostility to the disease’s two main risk groups; gay men and intravenous drug users.

    18 August 2016 | Box Turtle Bulletin
  • Cancer drug companies cut prices to win NHS approval

    Tougher new policy by regulator means pharma firms are having to offer better value for money to get treatments accepted by NHS.

    18 August 2016 | The Guardian
  • The end of the end of AIDS

    The Durban 2016 AIDS Conference marks the end of "ending the HIV epidemic" as a feasible goal with the tools we have. We need new and better tools. Talk of ending AIDS has led to a widespread perception in the broader health and development community that this crisis is over. It isn't.

    16 August 2016 | World Bank (blog)
  • Brexit: What does it mean for development aid and the Global Fund?

    Britain’s vote to leave the European Union has left much of the global development community wondering what this will mean for the UK’s role as a global leader in international aid and development. It also raises issues about the implications for the Global Fund’s Fifth Replenishment.

    03 August 2016 | Global Fund Observer
  • PrEP rationing is symptomatic of NHS bid to cut costs, at all costs

    NHS England’s setback in the high court over its attempt to get one set of cash-strapped public bodies (local councils) to foot the £10m-£20m a year bill for PrEP treatment rather than another – itself – is the latest manifestation of the health service’s increasing efforts to reduce the number of treatments it pays for, or the number of patients who receive them, or both.

    03 August 2016 | The Guardian
  • South Africa: Mark Heywood - Nodding Along to Protesters At #Aids2016 Is Not Enough

    Mark Heywood, the director of social justice organisation Section27 and a board member of the Treatment Action Campaign addressed the media on the sidelines of the International Aids conference on Tuesday. This is a transcript of his speech.

    20 July 2016 | AllAfrica
  • US Aids funding 'would continue under Trump'

    Deborah Birx, global Aids co-coordinator for the US, tells the BBC Aids funding would continue if Donald Trump became president.

    20 July 2016 | BBC Health
More news

Our information levels explained

  • Short and simple introductions to key HIV topics, sometimes illustrated with pictures.
  • Expands on the previous level, but also written in easy-to-understand plain language.
  • More detailed information, likely to include medical and scientific language.
  • Detailed, comprehensive information, using medical and specialised language.
Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap
close